Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
8 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
A Rare Case of Hepatic Vanishing Bile Duct Syndrome Occurring after Combination Therapy with Nivolumab and Cabozantinib in a Patient with Renal Carcinoma.
Diagnostics (Basel). 2022 Feb 19;12(2):539. doi: 10.3390/diagnostics12020539.
Diagnostics (Basel). 2022.
PMID: 35204627
Free PMC article.
Biomarkers and immunotherapy: where are we?
Langouo Fontsa M, Padonou F, Willard-Gallo K.
Langouo Fontsa M, et al.
Curr Opin Oncol. 2022 Sep 1;34(5):579-586. doi: 10.1097/CCO.0000000000000891.
Curr Opin Oncol. 2022.
PMID: 35943441
Review.
Item in Clipboard
The impact of tumor cell metabolism on T cell-mediated immune responses and immuno-metabolic biomarkers in cancer.
Noël G, Langouo Fontsa M, Willard-Gallo K.
Noël G, et al. Among authors: langouo fontsa m.
Semin Cancer Biol. 2018 Oct;52(Pt 2):66-74. doi: 10.1016/j.semcancer.2018.03.003. Epub 2018 Mar 21.
Semin Cancer Biol. 2018.
PMID: 29574171
Review.
Item in Clipboard
Thromboembolism and Immune Checkpoint Blockade in Cancer Patients: An Old Foe for New Research.
Langouo Fontsa M, Aiello MM, Migliori E, Scartozzi M, Lambertini M, Willard-Gallo K, Solinas C.
Langouo Fontsa M, et al.
Target Oncol. 2022 Sep;17(5):497-505. doi: 10.1007/s11523-022-00908-8. Epub 2022 Sep 14.
Target Oncol. 2022.
PMID: 36102923
Review.
Item in Clipboard
Sequential use of protein kinase inhibitors potentiates their toxicity to melanoma cells: a rationale to combine targeted drugs based on protein expression inhibition profiles.
Aftimos PG, Wiedig M, Langouo Fontsa M, Awada A, Ghanem G, Journe F.
Aftimos PG, et al. Among authors: langouo fontsa m.
Int J Oncol. 2013 Sep;43(3):919-26. doi: 10.3892/ijo.2013.2008. Epub 2013 Jul 8.
Int J Oncol. 2013.
PMID: 23835698
Item in Clipboard
Can we yet use tertiary lymphoid structures as predictive biomarkers for immunotherapy response in melanoma?
Padonou F, Vanhulst T, Langouo-Fontsa MD.
Padonou F, et al. Among authors: langouo fontsa md.
Curr Opin Oncol. 2024 Mar 1;36(2):63-68. doi: 10.1097/CCO.0000000000001015. Epub 2024 Jan 19.
Curr Opin Oncol. 2024.
PMID: 38441065
Review.
Item in Clipboard
Single agent vs combination immunotherapy in advanced melanoma: a review of the evidence.
Benhima N, Belbaraka R, Langouo Fontsa MD.
Benhima N, et al. Among authors: langouo fontsa md.
Curr Opin Oncol. 2024 Mar 1;36(2):69-73. doi: 10.1097/CCO.0000000000001014. Epub 2024 Jan 2.
Curr Opin Oncol. 2024.
PMID: 38193381
Review.
Item in Clipboard
[An atypical presentation of bronchial adenocarcinoma].
Langouo Fontsa M, Cstoth I, Berghmans T, Feoli F, Meert AP.
Langouo Fontsa M, et al.
Rev Med Brux. 2013 May-Jun;34(3):181-3.
Rev Med Brux. 2013.
PMID: 23951859
French.
Item in Clipboard
Cite
Cite